Ultrasound scan to find insulin skin lumps and improve sugar control
Part of Hormones & metabolism clinical trials.
This study uses an ultrasound scan to find fatty lumps on the skin caused by insulin injections (called lipohypertrophy). It aims to help you improve blood sugar control by identifying and addressing where insulin is being injected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes
- You use insulin every day (at least one injection per day) or an insulin pump
- You’ve been on your current insulin routine for at least 2 years
- You are not taking a GLP-1 medicine (a drug like liraglutide, semaglutide, or similar)
- You are not using steroid pills or other whole-body steroid medicines
- Your usual insulin injection skin area does not have a past non–fatty-lump skin problem
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
This study tests whether using ultrasound scans in diabetes clinics can help people avoid insulin-induced lipohypertrophy (lumps under the skin from injections). It is for people with diabetes who use insulin injections or a pump and have unstable glucose levels despite using a continuous glucose monitor.
This study tests whether a series of ultrasound treatments can improve blood sugar control in people with type 2 diabetes. You may be asked to stay on your current diabetes pills and avoid certain other medicines during the study.
This study tests whether focused ultrasound can help people with type 2 diabetes by gently stimulating nerves. It may offer a new way to improve glucose control without medication.
This study tests a new, less invasive way to remove fatty lumps (lipomas) using ultrasound to guide a special treatment that breaks them down. It aims to reduce scarring and improve cosmetic results compared to traditional surgery.
This early-stage study tests an investigational insulin (HDV-insulin lispro) given by injection, to see how it affects glucose production in the liver and overall blood sugar control. Participation involves dose-response testing and monitoring, which may help guide future diabetes treatment.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.